Age is the most significant risk factor for macular degeneration. Being 50 or older increases your chance of developing age-related macular degeneration. Some studies suggest you have a slightly ...

Note: Many studies combine these two nutrients with others, such as vitamins C and E. It may be that the mix of nutrients does more for your eyes than any single one of them. Recommended daily ...

You may have heard about recent research suggesting that certain nutrients can help delay or prevent eye problems and disease. You may also have heard a lot of claims for over-the-counter (OTC ...

The Inverclyde Macular Society Support Group meets on the fourth Thursday of each month (excluding December and January), from 11am to 12.30pm at Your Voice, 51 Hamilton Way, Greenock. Run in ...

From expanding an infectious disease assay portfolio to pioneering an imaging system to enhance space biology, here are the products, partnerships and publications that have been announced over the ...

Purpose To explore the factors and frequency of interruptions in intravitreal treatment for patients with neovascular age-related macular degeneration (AMD) and to evaluate the demographic and ...

That’s more often true when eyesight changes are caused by a condition such as age-related macular degeneration, glaucoma or diabetic retinopathy. These conditions become more common with age ...

According to a study published in the National Center for Biotechnology Information, the prevalence of macular edema is anywhere from 4.2% to 7.9% in patients with type 1 diabetes and 1.4% to 12.8% in ...

Syfovre (pegcetacoplan) is a prescription injection used in adults to treat geographic atrophy due to a certain type of age-related macular degeneration (AMD). Syfovre comes as a solution that’s ...

Macular degeneration is very common and affects an estimated 19.8 million people in the United States. Approximately one in 10 Americans age 50 and older have an early form of the disease and as many ...